دورية أكاديمية

Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients.

التفاصيل البيبلوغرافية
العنوان: Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients.
المؤلفون: Zhang, Yan, Wang, Jin, Zhao, Li-Mei, Peng, Wei, Shen, Guo-Qing, Xue, Ling, Zheng, Xiao-Xian, HE, Xiao-Jing, Gong, Chun-Yan, Miao, Li-Yan
المصدر: European Journal of Clinical Pharmacology; Sep2011, Vol. 67 Issue 9, p885-887, 3p, 1 Chart
مصطلحات موضوعية: ACADEMIC medical centers, ANALYSIS of variance, CARBAMAZEPINE, CHI-squared test, FISHER exact test, GENES, GENETIC techniques, POLYMERASE chain reaction, RESEARCH funding, TOXIC epidermal necrolysis, STEVENS-Johnson Syndrome, GENETICS
مصطلحات جغرافية: CHINA
مستخلص: Purpose: The purpose of this study is to examine the association of HLA-B*1502 allele with CBZ-induced SJS/TEN in the mainland Han Chinese population. Methods: HLA-B*1502 genotyping with sequence-specific primer polymerase chain reaction (PCR-SSP) and PCR-sequencing based typing (PCR-SBT) was performed on 17 CBZ-induced SJS/TEN patients, 21 CBZ-tolerant controls, and 185 healthy controls recruited during 2008-2010. Results: HLA-B*1502 allele was present in 94.1% (16/17) of CBZ-SJS/TEN patients, 9.5% (2/21) of CBZ-tolerant patients, and 9.2% (17/185) of healthy controls. The risk of CBZ-induced SJS/TEN was significantly higher ( P < 0.01) in the patients with HLA-B*1502. One CBZ-induced SJS patient tested negative for HLA-B*1502, and the test result showed HLA-B*3503/B*4601. Conclusions: We found a strong association between HLA-B*1502 and CBZ-induced SJS/TEN in the Han Chinese population from central and northern China. Combined with previous studies of the southern Han Chinese subpopulation, our results suggest that HLA-B*1502 is strongly associated with CBZ-induced SJS/TEN in the whole Han Chinese population. [ABSTRACT FROM AUTHOR]
Copyright of European Journal of Clinical Pharmacology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00316970
DOI:10.1007/s00228-011-1009-4